To demonstrate the presence of an independent renin–angiotensin system (RAS) in the peritoneum and to determine the role of locally produced angiotensin (Ang) II in high glucose-induced upregulation of transforming growth factor (TGF)-β1 and fibronectin by human peritoneal mesothelial cells (HPMC).
Methods
In cultured HPMC, the expression of mRNAs for angiotensinogen, angiotensin-converting enzyme (ACE), Ang II type 1 receptor (AT1), and TGF-β1 was evaluated by real-time polymerase chain reaction; ACE, AT1, and fibronectin proteins by Western blot analysis; and Ang I, Ang II, and TGF-β1 proteins by ELISA. Dichlorofluorescein (DCF)-sensitive cellular reactive oxygen species (ROS) were measured by fluorometry.
Results
HPMC constitutively expressed all the components of RAS, and 50 mmol/L D-glucose (high glucose) significantly increased angiotensinogen, ACE, and AT1 mRNAs and ACE, AT1, and Ang II proteins. Ang II increased TGF-β1 and fibronectin protein expression and DCF-sensitive cellular ROS. Losartan prevented Ang II-induced increase in cellular ROS. Both losartan and captopril inhibited high glucose-induced upregulation of TGF-β1 and fibronectin expression in HPMC in a dose-dependent manner. Antioxidant catalase and NADPH oxidase inhibitor diphenyleneiodinium effectively inhibited Ang II-induced TGF-β1 and fibronectin protein expression.
Conclusions
The present data demonstrate that HPMC constitutively express RAS, that Ang II produced by HPMC mediates high glucose-induced upregulation of TGF-β1 and fibronectin expression, and that Ang II-induced TGF-β1 and fibronectin expression in HPMC is mediated by NADPH oxidase-dependent ROS. These data suggest that locally produced Ang II and ROS in the peritoneum may be potential therapeutic targets in peritoneal fibrosis during long-term peritoneal dialysis.
WilliamsJ.D., CraigK.J., TopleyN., Von RuhlandC., FallonM., NewmanG.R.Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease.J Am Soc Nephrol2002; 13: 470–9.
2.
DaviesS.J., PhillipsL., NaishP.F., RussellG.I.Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis.J Am Soc Nephrol2001; 12: 1046–51.
3.
HeimbürgerO., WaniewskiJ., WerynskiA., TranaeusA., LindholmB.Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity.Kidney Int1990; 38: 495–506.
4.
HaH., YuM.R., LeeH.B.High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells.Kidney Int2001; 59: 463–70.
5.
LeeH.B., YuM.R., SongJ.S., HaH.Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by peritoneal mesothelial cells.Kidney Int2004; 65: 1170–9.
6.
HaH., ChaM.K., ChoiH.N., LeeH.B.Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.Perit Dial Int2002; 22: 171–7.
7.
ZweersM.M., StruijkD.G., SmitW., KredietR.T.Vascular endothelial growth factor in peritoneal dialysis: A longitudinal follow-up.J Lab Clin Med2001; 137: 125–32.
TakahashiK., HataJ., MukaiK., SawasakiY.Close similarity between cultured human omental mesothelial cells and endothelial cells in cytochemical markers and plasminogen activator production.In Vitro Cell Dev Biol1991; 27A: 542–8.
16.
Chung-WelchN., PattonW.F., Yen-PattonG.P.A., HechtmanH.B., SheproD.Phenotypic comparison between mesothelial and microvascular endothelial cell lineages using conventional endothelial cell markers, cytoskeletal protein markers and in vitro assays of angiogenic potential.Differentiation1989; 42: 44–53.
17.
KuwaharaM., MiyajiT., TsuboneH., KuwaharaM.Angiotensin II type 1 receptor-mediated increase in cytosolic Ca2+ and proliferation in mesothelial cells.Eur J Pharmacol2000; 388: 21–7.
18.
SimpsonD.A., FeeneyS., BoyleC., StittA.W.Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR.Mol Vis2000; 6: 178–83.
19.
Ramos-PayanR., Aguilar-MedinaM., Estrada-ParraS., Gonzalez-Y-MerchandJ.A., Favila-CastilloL., Monroy-OstriaA.Quantification of cytokine gene expression using an economic real-time polymerase chain reaction method based on SYBR green I.Scand J Immunol2003; 57: 439–45.
20.
BradfordM.M.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem1976; 72: 248–54.
21.
JiangZ., SeoJ.Y., HaH., LeeE.A., KimY.S., HanD.C.Reactive oxygen species mediate TGF-β1-induced plasminogen activator inhibitor-1 upregulation in mesangial cells.Biochem Biophys Res Commun2003; 309: 961–6.
22.
BaderM., PetersJ., BaltatuO., MullerD.N., LuftF.C., GantenD.Tissue renin-angiotensin systems: New insights from experimental animal models in hypertension research.J Mol Med2001; 79: 76–102.
23.
MorimotoS., SigmundC.D.Angiotensin mutant mice: A focus on the brain renin-angiotensin system.Neuropeptides2002; 36: 194–200.
24.
EngeliS., NegrelR., SharmaA.M.Physiology and pathophysiology of the adipose tissue renin-angiotensin system.Hypertension2000; 35: 1270–7.
SinghR., SinghA.K., AlaviN., LeeheyD.J.Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose.J Am Soc Nephrol2003; 14: 873–80.
29.
VidottiD.B., CasariniD.E., CristovamP.C., LeiteC.A., SchorN., BoimM.A.High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells.Am J Physiol2004; 286: F1039–45.
30.
SodhiC.P., KanwarY.S., SahaiA.Hypoxia and high glucose upregulate AT1 receptor expression and potentiate ANG II-induced proliferation in VSM cells.Am J Physiol Heart Circ Physiol2003; 284: H846–52.
31.
DurvasulaR.V., PichlerR.H., PippinJ.W., GriffinS.V., CouserW.G., ShanklandS.J.Activation of a local angiotensin system by high glucose in cultured podocytes [Abstract].J Am Soc Nephrol2003; 14: 389A.
32.
SechiL.A., GriffinC.A., SchambelanM.The cardiac renin-angiotensin system in STZ-induced diabetes.Diabetes1994; 43: 1180–4.
33.
Harrison-BernardL.M., ImigJ.D., CarminesP.K.Renal AT1 receptor protein expression during the early stage of diabetes mellitus.Int J Exp Diabetes Res2002; 3: 97–108.
34.
AmiriF., GarciaR.Regulation of angiotensin II receptors and PKC isoforms by glucose in rat mesangial cells.Am J Physiol1999; 276: F691–9.
35.
BallermanB.J., SkoreckiK.L., BrennerB.M.Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat.Am J Physiol1984; 247: F110–16.
36.
ChengH.F., BurnsK.V., HarrisR.C.Reduced proximal tubule angiotensin II receptor expression in streptozotocin-induced diabetes mellitus.Kidney Int1994; 46: 1603–10.
37.
KagamiS., BorderW.A., MillerD.E., NobelN.A.Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.J Clin Invest1994; 93: 2431–7.
38.
WolfG., MuellerE., StahlR.A., ZiyadehF.N.Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta.J Clin Invest1993; 92: 1366–72.
39.
GriendlingK.K., SorescuD., Ushio-FukaiM.NAD(P)H oxidase: Role in cardiovascular biology and disease.Circ Res2000; 86: 494–501.
40.
LiJ.M., ShahA.M.Mechanism of endothelial cell NADPH oxidase activation by angiotensin II.J Biol Chem2003; 278: 12094–100.
41.
RunyanC.E., SchnaperH.W., PonceletA.C.Smad3 and PKCδ mediate TGF-β1-induced collagen I expression in human mesangial cells.Am J Physiol Renal Physiol2003; 285: F413–22.
